NIH Budget Cut At $142 Million, NCI Could Get Small Increase Over 1981 Total; Schweiker Backs NIH Funds
In Brief: NCI Holding Up Regional Cooperative Group RFA Until Department Approves New Mechanism
Basic Biology Progress, Improved Survival Since 1971 Described By DeVita At Senate Hearing
NTP Committee Finds Five Test Reports Show “Limited” Evidence Of Carcinogenicity
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
